Gov. Cox taps former Utah AG records counsel as new public records director
Utah Gov. Spencer Cox has appointed a former Utah Attorney General's Office attorney to fill a new role that will be a key decision-maker over which government records do — and don't — become public.
Cox picked Lonny Pehrson, who most recently worked as records counsel for the Utah Attorney General's Office, to be the first director of the state's newly created Government Records Office. His nomination will be subject to consent from the Utah Senate.
'We look forward to the Government Records Office streamlining the appeals process and helping Utahns get timely answers to their records requests,' Cox said in a prepared statement. 'Lonny Pehrson's legal expertise and commitment to good governance make him the right person to lead this important effort.'
Pehrson said he's 'honored' for Cox's nomination 'and truly appreciate the trust and responsibility it entails.'
Utah lawmakers look to dissolve, replace State Records Committee. Here's why that matters
'I look forward to establishing the Government Records Office which will better facilitate access to government records in accordance with the law,' Pehrson said in a prepared statement.
Earlier this year, the Utah Legislature voted to approve SB277, which dissolved and replaced the 30-year-old, seven-member State Records Committee with a single decision-maker. At the time, the bill's sponsor, Senate Majority Assistant Whip Mike McKell, R-Spanish Fork, said the change is meant to address 'inefficiencies,' cut down on wait times for records decisions, and replace the State Records Committee with someone with more 'legal experience.'
Critics, including media professionals, argued the move would consolidate too much power with one person and lead to less transparency. The Society of Professional Journalists awarded the Utah Legislature its annual Black Hole award for the passage SB277, along with another, HB69, which made it difficult for people who challenge the government over public records denials to recoup their attorney fees.
Pehrson, in his new role, will now decide appeals to records requests that have been denied. He'll be responsible for adjudicating records appeals hearings and supervising the Government Records Ombudsman and staff.
'He will also serve as a resource to citizens and governmental entities regarding government records management, ensuring lawful access to records and information, and leading a team that conducts statewide training in records and information management,' a news release issued Monday by the Division of Archives and Records Service said.
'Disregard for transparency': Utah Legislature's public records laws earn it a 'Black Hole' award
Pehrson, in his previous role as records counsel for then-Utah Attorney General Sean Reyes, argued against releasing Reyes' calendar in response to requests from local news outlets KSL and The Salt Lake Tribune.
The State Records Committee ultimately sided with reporters, and in February a judge ruled that Reyes' work calendar should be released. The same day as the judge's ruling, however, the Utah Legislature passed a bill to allow elected officials and government employees the ability to keep their calendars — including work meetings — private moving forward.
Reyes didn't seek reelection last year after concerns surfaced over his past relationship with the embattled anti-trafficking nonprofit Operation Underground Railroad and its founder, Tim Ballard. Earlier this year, a legislative audit of Reyes' administration concluded that 'insufficient transparency' resulted in 'a lack of accountability for the position of the attorney general.'
State leaders, however, applaud Pehrson as an expert in Utah's public records law, the Government Records Access and Management Act (GRAMA).
Kenneth Williams, director of the Utah Division of Archives and Records Service and state archivist, said in a statement that his department is 'thrilled' to welcome Pehrson.
'I have worked with Lonny for several years and know that his expertise in records law and dedication to public service will be invaluable as we continue to ensure appropriate and reliable access to government records for the people of Utah,' Williams said.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
AstraZeneca announces $50bn US investment plans by 2030
AstraZeneca has announced $50bn investment plans in the US by 2030 for drug manufacturing, and research and development (R&D). The investment represents a substantial capital infusion to the $3.5bn announced in November 2024. The focus of this investment is a manufacturing facility dedicated to producing drug substances for AstraZeneca's weight management and metabolic product range. This portfolio includes oral glucagon-like peptide-1 (GLP-1), baxdrostat, oral proprotein convertase subtilisin/kexin type 9 (PCSK9) and combination small molecule treatments. The new facility will be designed to manufacture peptides, small molecules and oligonucleotides. To be constructed in the Commonwealth of Virginia, the plant will be AstraZeneca's single manufacturing venture globally. The new facility will incorporate advanced technologies such as AI, automation and data analytics to enhance production capabilities. This financial commitment will generate new direct and indirect jobs in the US. AstraZeneca CEO Pascal Soriot stated: 'Today's announcement underpins our belief in America's innovation in biopharmaceuticals and our commitment to the millions of patients who need our medicines in America and globally. It will also support our ambition to reach $80bn in revenue by 2030.' The investment also covers other projects: the expansion of AstraZeneca's R&D facility in Gaithersburg, Maryland, and the establishment of an advanced R&D centre in Kendall Square, Cambridge, Massachusetts. The company will also develop next-generation manufacturing facilities for cell therapy in Rockville, Maryland and Tarzana, California, as well as expand its continuous manufacturing operations in Mount Vernon, Indiana. The investment encompasses the expansion of speciality manufacturing in Coppell, Texas, the establishment of new sites to support clinical trials, and an increase in funding for research and development of new medicines. In July 2025, Modella AI entered a multi-year partnership with AstraZeneca aimed at accelerating AI-driven clinical development in oncology. "AstraZeneca announces $50bn US investment plans by 2030" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


The Hill
11 hours ago
- The Hill
Rep. Gabe Evans (R-CO) discusses the DIGNITY Act
Rep. Gabe Evans (R-CO) joins The Hill on NewsNation to discuss the DIGNITY Act, a bipartisan effort being relaunched to reform immigration laws.
Yahoo
15 hours ago
- Yahoo
Factories, Data Centers Will Get A Boost From The 'One Big, Beautiful Bill'
The manufacturing sector is set to get a big boost from President Donald Trump's 'One Big, Beautiful Bill,' which is likely to spur new waves of investment, especially in sectors like AI and biotechnology. The sprawling budget bill introduces a series of tax deductions and credits for businesses, especially those that invest in research and development (R&D), AI buildouts, and domestic factory construction. 'Likely beneficiaries of the law include industrial machinery manufacturers, heating and ventilation system providers, pharmaceutical innovators, semiconductor companies and major technology firms,' wrote Matt Hochstetler, equity portfolio manager at Capital Group. Bigger Up-Front Tax Breaks to Create Cash Flow One of the bill's main provisions benefiting manufacturing is a change to how quickly companies can claim tax breaks on investments in equipment, facilities, and production lines. The bill now lets companies deduct 100% of their investment in 'qualified production property' in the year it's paid for instead of spreading the deduction over several years. 'This measure could become a powerful tailwind for free cash flow and spur fresh waves of investment across multiple sectors, assuming overall debt levels don't drive interest rates too high,' Hochstetler wrote. Because both the factory itself and the machinery inside can be deducted immediately, some analysts said this could incentivize companies to build more of their supply chains in the U.S. 'This 'reshoring super-deduction' dramatically lowers the after-tax cost of domestic investment. This should encourage the onshoring of supply chains and manufacturing capacity and create more jobs for Americans,' wrote Brownstone Research Senior Analyst Nick Rokke. AI Will Be A Big Winner The bill offers immediate deductions for investments made into research and development, including retroactively from 2022. The bill also boosts the tax credit for semiconductor production to 35% from 25% previously. Together, these changes could provide a boon for AI production in the U.S., especially amid a surge in data center construction by companies like Microsoft (MSFT), Alphabet (GOOG), Amazon (AMZN), and Meta Platforms (META). 'With new data center costs reaching into the tens of billions of dollars, the short-term tax savings are enormous,' Rokke wrote. 'This change alone frees up billions in cash flow for the hyperscalers. And that cash will almost certainly be reinvested into even more compute infrastructure.' Smaller Factories Get a Leg Up Another provision that could benefit manufacturers is the restoration of deductions based on earnings before interest, taxes, depreciation, and amortization, or EBITDA. The Association of Manufacturing Technology (AMT) said this would allow for greater deductibility of interest expenses related to financing investments, acquisitions and expansions. The group also pointed to higher expensing limits for small businesses, which it said would allow for larger equipment purchases. 'This change dramatically increases the ability of small manufacturers to invest upfront in critical assets, leveling the playing field against larger competitors,' wrote Amber Thomas, AMT vice president of advocacy. An increase in the estate tax exemption is another benefit for small business owners, AMT pointed out. That provision could help family-owned manufacturing businesses pass on ownership without facing burdensome taxes. Read the original article on Investopedia Sign in to access your portfolio